Oxford cancer symptoms paper is the second most read paper in the British Journal of General Practice in 2021
21 January 2022
The team identified new symptoms that could help doctors diagnose pancreatic cancer.
New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread
5 January 2022
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.
New study highlights importance of early diagnosis for ovarian cancer survival
23 December 2021
Analysis of data from the Million Women Study demonstrates the association between stage at diagnosis and survival.
Study sheds new light on the association between an infectious bacterium and gastric cancer in China
1 December 2021
Helicobacter pylori infection increases the risk of both cardia gastric cancer and non-cardia gastric cancer in the China Kadoorie Biobank.
New partnership for Oxford early cancer detection research spin-out
29 November 2021
Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.
MP Anneliese Dodds tours Oxford cancer research
26 November 2021
Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including the work of OxCODE members.
World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition
23 November 2021
The University of Oxford will lead a £2m national cancer prevention trial in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.
Fewer cases of children’s cancer picked up during the COVID pandemic
12 November 2021
An Oxford study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic, but cancer diagnosis in children following admission to intensive care was higher.
Datasets used to train AI to detect skin cancer are insufficient and lacking in pictures of darker skin
10 November 2021
Work by researchers at Oxford University Hospitals has highlighted how the images and accompanying data available for training artificial intelligence (AI) to spot skin cancer are insufficient and include very few images of darker skin.
New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Dr Weiqi Liao and Professor Julia Hippisley-Cox have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms.
Identifying early clinical features of myeloma in primary care
28 October 2021
Research by Dr Karthik Ramasamy into the earlier recognition of myeloma symptoms in primary care aims to accelerate myeloma diagnosis.
Impact award for publication on ovarian cancer
26 October 2021
A paper led by Dr Zhiyuan Hu from Professor Ahmed Ahmed’s lab has won the Columbia Hospital for Women Research Foundation’s 2020-2021 prize for impact.
Pancreatic cancer early detection funds awarded to OxCODE researchers
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
OxCODE researchers at the Early Detection of Cancer Conference 2021
13 October 2021
Oxford’s early detection research was featured at this annual event.
Turing Fellowships for four OxCODE members
30 September 2021
Hashem Koohy, Rafael Perera, Benjamin Schuster-Böckler and Clare Verrill will join the Turing network for 2021-2022 to further their research in cancer big data.
Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
15 September 2021
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri™ in suspected cancer patients.
Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection
2 September 2021
Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.
OxCODE funds three early detection projects
27 August 2021
Congratulations to Alistair Easton, Siim Pauklin, Susie Shapiro and their collaborators who have been awarded funding in the second round of the OxCODE Funding Scheme.
Oxford spin-out partners with Johnson & Johnson to improve lung cancer survival rates
18 August 2021
Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.
New network Oxford Cancer launches
14 July 2021
OxCODE is working under the umbrella of a new pan-divisional initiative at the University of Oxford that brings together the collective force of cancer research, outreach and care that happen across the city of Oxford.